You have 9 free searches left this month | for more free features.

Familial ATTR-PN

Showing 1 - 25 of 1,285

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,

Recruiting
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • +2 more
  • NTLA-2001
  • Paris, France
  • +3 more
Nov 29, 2022

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial (Acoramidis)

Withdrawn
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • (no location specified)
Jan 26, 2022

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial in San Francisco (AG10, Placebo)

Withdrawn
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • San Francisco, California
    Eidos Therapeutics
Jun 11, 2021

Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)

Not yet recruiting
  • Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
  • NTLA-2001
  • Placebo
  • (no location specified)
Nov 8, 2023

Amyloidosis, Hereditary Trial in Richmond (Registry)

Not yet recruiting
  • Amyloidosis, Hereditary
  • Registry
  • Richmond, Virginia
    Virginia Commonwealth University
Jul 25, 2023

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Not yet recruiting
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • +2 more
    • Auckland, New Zealand
    • +2 more
    Jan 24, 2023

    Transthyretin Amyloid Polyneuropathy (ATTR-PN) Trial in China (tafamidis meglumine)

    Active, not recruiting
    • Transthyretin Amyloid Polyneuropathy (ATTR-PN)
    • tafamidis meglumine
    • Beijing, Beijing, China
    • +7 more
    Nov 21, 2022

    Hereditary Transthyretin Amyloidosis Patients Included in

    Completed
    • Hereditary Transthyretin Amyloidosis (ATTRv)
    • Polyneuropathy
    • Barcelona, Spain
    • +2 more
    Dec 23, 2022

    Transthyretin Amyloidosis, Heart Failure, Heart Failure, Diastolic Trial in Boston (99mTc-pyrophosphate Scintigraphy)

    Recruiting
    • Transthyretin Amyloidosis
    • +3 more
    • 99mTc-pyrophosphate Scintigraphy
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 11, 2022

    Transthyretin Amyloidosis in Left Ventricular Hypertrophy of

    Completed
    • Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
    • Diagnosis of TTR amyloidosis cardiomyopathy
    • Chermside, Australia
    • +17 more
    Nov 3, 2022

    Hereditary Transthyretin Amyloidosis With Polyneuropthy Trial in Canada, United States (Blood samples for immunoglobulins, Blood

    Recruiting
    • Hereditary Transthyretin Amyloidosis With Polyneuropthy
    • Blood samples for immunoglobulins
    • +2 more
    • Rosedale, New York
    • +3 more
    Dec 19, 2022

    Prospective Evaluation of NfL as a Biomarker in ATTRv

    Not yet recruiting
    • Amyloidosis, Hereditary
      • (no location specified)
      May 18, 2023

      Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR

      Not yet recruiting
      • Amyloidosis, Hereditary
      • +4 more
        • New York, New York
        • +2 more
        Aug 3, 2022

        Study of Patients With hATTR-PN

        Recruiting
        • Hereditary Transthyretin Amyloidosis With Polyneuropthy
        • Data Collection
        • Anchorage, Alaska
        • +22 more
        Feb 1, 2023

        Lumbar Spine Stenosis Specimens for Identification of

        Not yet recruiting
        • Lumbar Spinal Stenosis
        • +5 more
        • Tc99-PYP or Tc99-HDMP Scan
        • Beverly Hills, California
        • +5 more
        Sep 12, 2023

        Familial ATTR-CM (ATTRm-CM, or FAC) and Wild-type ATTR-CM (ATTRwt-CM) Trial in United States (AG10, Placebo Oral Tablet)

        Completed
        • Familial ATTR-CM (ATTRm-CM, or FAC)
        • Wild-type ATTR-CM (ATTRwt-CM)
        • AG10
        • Placebo Oral Tablet
        • Beverly Hills, California
        • +12 more
        Oct 24, 2022

        Familial Amyloidotic Polyneuropathy (BioTRAP)

        Completed
        • Transthyretin Amyloidosis
        • +2 more
          • Rostock, Germany
          • +1 more
          May 4, 2021

          ATTR-PN Trial in Worldwide (Tafamidis)

          Completed
          • ATTR-PN
          • Baltimore, Maryland
          • +8 more
          Jul 7, 2021

          Mitral Regurgitation, ATTR-Cardiomyopathy, Edge-to-Edge Mitral Valve Repair Trial (TEER, Optimal Medical Therapy)

          Not yet recruiting
          • Mitral Regurgitation
          • +2 more
          • TEER
          • Optimal Medical Therapy
          • (no location specified)
          Oct 4, 2023

          Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)

          Recruiting
          • Transthyretin Amyloidosis
          • I 124-Evuzamitide
          • New York, New York
            Columbia University Irving Medical Center
          Nov 23, 2022

          Aortic Stenosis and Cardiac Amyloidosis

          Recruiting
          • Cardiac Amyloidosis
          • Aortic Stenosis
          • Amyloid-specific treatment
          • No amyloid-specific treatment
          • Vienna, Austria
          • +1 more
          Nov 8, 2023

          Study of Transthyretin-Mediated Amyloidosis

          Recruiting
          • Transthyretin-Mediated Amyloidosis
          • ATTR Amyloidosis
            • La Jolla, California
            • +23 more
            Jan 13, 2023

            Hereditary Transthyretin Amyloidosis

            Recruiting
            • Amyloidosis
            • +6 more
              • Cleveland, Ohio
                Cleveland Clinic
              Mar 11, 2022

              Cardiomyopathies, Primary Trial ((18F)Flutemetamol)

              Recruiting
              • Cardiomyopathies, Primary
              • New Haven, Connecticut
                Yale University
              Oct 11, 2022

              Transthyretin Amyloidosis Trial in Beijin (Tafamidis Pill)

              Recruiting
              • Transthyretin Amyloidosis
              • Tafamidis Pill
              • Beijin, China
                Peking University Third Hospital
              Jul 7, 2021